Latent tuberculosis screening before kidney transplantation in the South of Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Jornal Brasileiro de Nefrologia |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021000400520 |
Resumo: | Abstract Background: Tuberculosis (TB) is a prevalent infection after kidney transplantation (KT) in high-burden countries. Latent tuberculosis infection (LTBI) screening includes previous TB history, chest radiograph findings, and tuberculin test (TST) and/or interferon-gamma release assays (IGRAs) results. We aimed to compare our routine LTBI screening of KT candidates and living donors (LD) with their IGRA results, and evaluate if this would improve isoniazid (INH) treatment referral. Methods: We evaluated adult KT candidates and LD with complete routine LTBI screening and QuantiFERON-TB® Gold In-Tube (QFT) testing. Blood samples were collected from April 4th, 2014 to October 31st, 2018, with follow-up until October 31st, 2019. Results: There were 116 KT recipients, with 30% QFT-positive results. Positive QFT was associated with past TB history (p=0.007), positive TST (p<0.0001), residual radiographic lesions (p=0.003), and diabetes (p=0.035). There were 25 LD, 40% had positive QFT. Positive QFT was associated with a positive TST (p=0.002). Positive QFT results increased INH referral in 80%. Post-transplant TB incidence was 2.6% in a median follow-up of 2 (1-33) months. No variables were associated with post-transplant TB. TB patients had inferior, although non-significant, 5-year graft survival (66.7% vs. 76.5%) (p = 0.402). Conclusion: In the present study, the association of QFT to our routine LTBI screening incremented INH treatment referral, but there was still a high incidence of post-transplant TB, possibly related to other forms of infection, such as new exposure and donor transmission. |
id |
SBN-1_1df5a839b10d307b573991758fe3dd42 |
---|---|
oai_identifier_str |
oai:scielo:S0101-28002021000400520 |
network_acronym_str |
SBN-1 |
network_name_str |
Jornal Brasileiro de Nefrologia |
repository_id_str |
|
spelling |
Latent tuberculosis screening before kidney transplantation in the South of BrazilKidney TransplantationTuberculosisLatent TuberculosisInterferon-gamma release assaysTuberculin TestAbstract Background: Tuberculosis (TB) is a prevalent infection after kidney transplantation (KT) in high-burden countries. Latent tuberculosis infection (LTBI) screening includes previous TB history, chest radiograph findings, and tuberculin test (TST) and/or interferon-gamma release assays (IGRAs) results. We aimed to compare our routine LTBI screening of KT candidates and living donors (LD) with their IGRA results, and evaluate if this would improve isoniazid (INH) treatment referral. Methods: We evaluated adult KT candidates and LD with complete routine LTBI screening and QuantiFERON-TB® Gold In-Tube (QFT) testing. Blood samples were collected from April 4th, 2014 to October 31st, 2018, with follow-up until October 31st, 2019. Results: There were 116 KT recipients, with 30% QFT-positive results. Positive QFT was associated with past TB history (p=0.007), positive TST (p<0.0001), residual radiographic lesions (p=0.003), and diabetes (p=0.035). There were 25 LD, 40% had positive QFT. Positive QFT was associated with a positive TST (p=0.002). Positive QFT results increased INH referral in 80%. Post-transplant TB incidence was 2.6% in a median follow-up of 2 (1-33) months. No variables were associated with post-transplant TB. TB patients had inferior, although non-significant, 5-year graft survival (66.7% vs. 76.5%) (p = 0.402). Conclusion: In the present study, the association of QFT to our routine LTBI screening incremented INH treatment referral, but there was still a high incidence of post-transplant TB, possibly related to other forms of infection, such as new exposure and donor transmission.Sociedade Brasileira de Nefrologia2021-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021000400520Brazilian Journal of Nephrology v.43 n.4 2021reponame:Jornal Brasileiro de Nefrologiainstname:Sociedade Brasileira de Nefrologia (SBN)instacron:SBN10.1590/2175-8239-jbn-2020-0189info:eu-repo/semantics/openAccessMeinerz,GiseleSilva,Cynthia Keitel daDorsdt,Damaris Mikaela BalinAdames,Julia BertoniAndrade,Julio PasqualiVentura,Pedro EnricoMonteiro,Alexandre de AlmeidaPasqualotto,Alessandro ComarúGarcia,Valter DuroKeitel,Elizeteeng2021-12-06T00:00:00Zoai:scielo:S0101-28002021000400520Revistahttp://www.bjn.org.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||jbn@sbn.org.br2175-82390101-2800opendoar:2021-12-06T00:00Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN)false |
dc.title.none.fl_str_mv |
Latent tuberculosis screening before kidney transplantation in the South of Brazil |
title |
Latent tuberculosis screening before kidney transplantation in the South of Brazil |
spellingShingle |
Latent tuberculosis screening before kidney transplantation in the South of Brazil Meinerz,Gisele Kidney Transplantation Tuberculosis Latent Tuberculosis Interferon-gamma release assays Tuberculin Test |
title_short |
Latent tuberculosis screening before kidney transplantation in the South of Brazil |
title_full |
Latent tuberculosis screening before kidney transplantation in the South of Brazil |
title_fullStr |
Latent tuberculosis screening before kidney transplantation in the South of Brazil |
title_full_unstemmed |
Latent tuberculosis screening before kidney transplantation in the South of Brazil |
title_sort |
Latent tuberculosis screening before kidney transplantation in the South of Brazil |
author |
Meinerz,Gisele |
author_facet |
Meinerz,Gisele Silva,Cynthia Keitel da Dorsdt,Damaris Mikaela Balin Adames,Julia Bertoni Andrade,Julio Pasquali Ventura,Pedro Enrico Monteiro,Alexandre de Almeida Pasqualotto,Alessandro Comarú Garcia,Valter Duro Keitel,Elizete |
author_role |
author |
author2 |
Silva,Cynthia Keitel da Dorsdt,Damaris Mikaela Balin Adames,Julia Bertoni Andrade,Julio Pasquali Ventura,Pedro Enrico Monteiro,Alexandre de Almeida Pasqualotto,Alessandro Comarú Garcia,Valter Duro Keitel,Elizete |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Meinerz,Gisele Silva,Cynthia Keitel da Dorsdt,Damaris Mikaela Balin Adames,Julia Bertoni Andrade,Julio Pasquali Ventura,Pedro Enrico Monteiro,Alexandre de Almeida Pasqualotto,Alessandro Comarú Garcia,Valter Duro Keitel,Elizete |
dc.subject.por.fl_str_mv |
Kidney Transplantation Tuberculosis Latent Tuberculosis Interferon-gamma release assays Tuberculin Test |
topic |
Kidney Transplantation Tuberculosis Latent Tuberculosis Interferon-gamma release assays Tuberculin Test |
description |
Abstract Background: Tuberculosis (TB) is a prevalent infection after kidney transplantation (KT) in high-burden countries. Latent tuberculosis infection (LTBI) screening includes previous TB history, chest radiograph findings, and tuberculin test (TST) and/or interferon-gamma release assays (IGRAs) results. We aimed to compare our routine LTBI screening of KT candidates and living donors (LD) with their IGRA results, and evaluate if this would improve isoniazid (INH) treatment referral. Methods: We evaluated adult KT candidates and LD with complete routine LTBI screening and QuantiFERON-TB® Gold In-Tube (QFT) testing. Blood samples were collected from April 4th, 2014 to October 31st, 2018, with follow-up until October 31st, 2019. Results: There were 116 KT recipients, with 30% QFT-positive results. Positive QFT was associated with past TB history (p=0.007), positive TST (p<0.0001), residual radiographic lesions (p=0.003), and diabetes (p=0.035). There were 25 LD, 40% had positive QFT. Positive QFT was associated with a positive TST (p=0.002). Positive QFT results increased INH referral in 80%. Post-transplant TB incidence was 2.6% in a median follow-up of 2 (1-33) months. No variables were associated with post-transplant TB. TB patients had inferior, although non-significant, 5-year graft survival (66.7% vs. 76.5%) (p = 0.402). Conclusion: In the present study, the association of QFT to our routine LTBI screening incremented INH treatment referral, but there was still a high incidence of post-transplant TB, possibly related to other forms of infection, such as new exposure and donor transmission. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021000400520 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021000400520 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/2175-8239-jbn-2020-0189 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Nefrologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Nefrologia |
dc.source.none.fl_str_mv |
Brazilian Journal of Nephrology v.43 n.4 2021 reponame:Jornal Brasileiro de Nefrologia instname:Sociedade Brasileira de Nefrologia (SBN) instacron:SBN |
instname_str |
Sociedade Brasileira de Nefrologia (SBN) |
instacron_str |
SBN |
institution |
SBN |
reponame_str |
Jornal Brasileiro de Nefrologia |
collection |
Jornal Brasileiro de Nefrologia |
repository.name.fl_str_mv |
Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN) |
repository.mail.fl_str_mv |
||jbn@sbn.org.br |
_version_ |
1752122066997346304 |